Environmental, Conservation Group Experts Join Bioethicists, University Researchers, and Scientists From Tree Growing Industry to Issue First-Ever Principles for the Responsible Use of Biotech Trees
09 déc. 2010 08h00 HE
|
Institute of Forest Biotechnology
RALEIGH, NC--(Marketwire - December 9, 2010) -
Note to Reporters: Online News Conference today at 11am Eastern.
To participate you'll need to call AND log on:
Call...
Media Alert: Leading University Researchers, Environmentalists, Industry Experts Join to Create Responsible Use Principles for Biotech Trees
06 déc. 2010 15h59 HE
|
Institute of Forest Biotechnology
WASHINGTON, DC--(Marketwire - December 6, 2010) -
WHAT:
A Webinar to unveil the "Responsible Use: Biotech Tree Principles" and discuss their intended worldwide use. Developed by...
Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo -- Previous Decision to Put Vacc-4x on Hold Has Been Reversed
18 nov. 2010 09h05 HE
|
Bionor Pharma
OSLO, NORWAY--(Marketwire - November 18, 2010) - After further analyses of the international, randomized, double-blind, placebo-controlled multi-center phase IIb study of Bionor Pharma's (OSLO:...
WHITECOAT Strategies Wins Top Honors for Video Production
18 nov. 2010 08h05 HE
|
WHITECOAT Strategies
WASHINGTON, DC--(Marketwire - November 18, 2010) - The Television, Internet and Video Association of DC (TIVA-DC) awarded WHITECOAT Strategies the gold medal for best public relations/marketing...
Novogen Appoints Three New Directors
20 sept. 2010 08h00 HE
|
Novogen Limited
SYDNEY, AUSTRALIA--(Marketwire - September 20, 2010) - Pharmaceutical development company, Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has appointed three new Directors.
Of the three...
Henrik Lund MD Ph.D, Former Global VP in Clinical Development at Astra Zeneca, Named New CEO of Bionor Pharma ASA
30 août 2010 09h14 HE
|
BionorPharma
OSLO, NORWAY--(Marketwire - August 30, 2010) - Bionor Pharma (OSLO: BIONOR) today announced that Henrik Lund MD Ph.D, will take over the position of CEO from Trond Syvertsen effective from 1...
Two Thirds of Study Volunteers Respond to First-Ever "Re-Vaccination" of Vacc-4x, Bionor Pharma's Peptide-Based Therapeutic HIV-Vaccine
30 août 2010 09h13 HE
|
BionorPharma
OSLO, NORWAY and WASHINGTON, DC--(Marketwire - August 30, 2010) -
Study Highlights: 25 volunteers from previously conducted Phase 2a trial were "re-vaccinated" with the vaccine after 7...
Novogen Limited Receives Nasdaq Notice
23 juil. 2010 08h00 HE
|
Novogen Limited
SYDNEY, AUSTRALIA--(Marketwire - July 23, 2010) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is listed on the Australian Stock Exchange and has an ADR program in place in the US through the...
"Next Generation" HIV/AIDS Treatments Featured in NAPWA and The AIDS Institute's Community Forum at XVIII International AIDS Conference
22 juil. 2010 11h07 HE
|
National Association of People with AIDS
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - New data presented by researchers at the XVIII International AIDS Conference this week shows significant momentum for the emerging field of...
Researchers Present Findings Today at the XVIII International AIDS Conference, Vienna Austria
22 juil. 2010 06h59 HE
|
BionorPharma
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - Researchers at Oslo University Hospital and Bionor Pharma's subsidiary, Bionor Immuno AS today presented results from a recently conducted...